BCAB BioAtla, Inc. - Common Stock
$3,61
Prix · Mai 20, 2026
Données fondamentales au Mai 15, 2026
Fourchette 52 semaines
$0–$8
43% of range
Note des analystes
STRONG BUY
7 analysts
Objectif de cours
—
P/E (TTM)
-0.6
ROE
—
Marge nette
—
BCAB Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$3.61
Capitalisation Boursière
—
P/E (TTM)
-0.6
BPA (TTM)
$-1.01
Revenus (TTM)
—
Rendement div.
—
ROE
—
Dette/Capitaux propres
—
Fourchette 52 semaines
$0 – $8
BCAB Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
—
2021-12-31
→
2021-12-31
BPA
$-1.01
2021-12-31
→
2025-12-31
Flux de trésorerie libre
—
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
BCAB
Médiane des pairs
P/E (TTM)
-0.6
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
BCAB
Médiane des pairs
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
BCAB
Médiane des pairs
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
BCAB
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
BCAB
Médiane des pairs
BCAB Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
7 analystes
- Achat fort 3 42,9%
- Achat 3 42,9%
- Conserver 1 14,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
2.4%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 décembre 2025 | $-8.00 | $-12.24 | 4.2% |
| 30 septembre 2025 | $-13.50 | $-15.13 | 1.6% |
| 30 juin 2025 | $-16.00 | $-17.21 | 1.2% |
| 31 mars 2025 | $-13.00 | $-17.68 | 4.7% |
| 31 décembre 2024 | $-0.30 | $-0.39 | 0.09% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| BCAB | — | -0.6 | — | — | — | — |
| BIAF | — | — | — | — | — | — |
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| XBIO | — | -1.4 | 19.0% | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| RNAZ | — | -0.1 | — | — | — | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| SNGX | $14M | -0.6 | -85.8% | — | -311.2% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $300.0K | |
| R&D Expense | $44M | $63M | $104M | $79M | $58M | |
| SG&A Expense | $18M | $22M | $26M | $29M | $38M | |
| Operating Expenses | $61M | $85M | $130M | $108M | $97M | |
| Operating Income | $-59M | $-74M | $-130M | $-108M | $-96M | |
| Interest Expense | · | · | · | $0 | $3.0K | |
| Interest Income | $843.0K | $3M | $6M | $2M | $350.0K | |
| Other Non-op | $-302.0K | $4M | $6M | $2M | $1M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-60M | $-70M | $-123M | $-106M | $-95M | |
| EPS (Basic) | $-1.01 | $-1.44 | $-2.58 | $-2.74 | $-2.76 | |
| EPS (Diluted) | $-1.01 | $-1.44 | $-2.58 | $-2.74 | $-2.76 | |
| Shares (Basic) | 58,827,934 | 48,573,364 | 47,777,568 | 38,927,268 | 34,561,245 | |
| Shares (Diluted) | 58,827,934 | 48,573,364 | 47,777,568 | 38,927,268 | 34,561,245 | |
| EBITDA | · | $-73M | $-128M | $-107M | $-95M |
Bilan 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $49M | $111M | $216M | $245M | |
| Prepaid Expense | $895.0K | $2M | $5M | $5M | $2M | |
| Current Assets | $8M | $51M | $116M | $220M | $247M | |
| PP&E (Net) | $120.0K | $678.0K | $2M | $3M | $4M | |
| PP&E (Gross) | $5M | $8M | $8M | $8M | $8M | |
| Accum. Depreciation | $5M | $7M | $6M | $5M | $4M | |
| Other Non-current Assets | $163.0K | $0 | $154.0K | $154.0K | $154.0K | |
| Total Assets | $14M | $52M | $120M | $226M | $254M | |
| Accounts Payable | $8M | $2M | $4M | $4M | $1M | |
| Current Liabilities | $22M | $15M | $28M | $23M | $20M | |
| Capital Leases | $5M | $0 | $836.0K | $2M | $4M | |
| Total Liabilities | $50M | $38M | $49M | $45M | $44M | |
| Common Stock | $0 | $6.0K | $5.0K | $5.0K | $4.0K | |
| Paid-in Capital | $509M | $500M | $487M | $473M | $397M | |
| Retained Earnings | $-546M | $-486M | $-416M | $-293M | $-186M | |
| Stockholders' Equity | $-36M | $14M | $71M | $180M | $211M | |
| Liabilities + Equity | $14M | $52M | $120M | $226M | $254M | |
| Shares Outstanding | 1,269,286 | 58,099,164 | 48,077,599 | 46,336,166 | 35,799,233 |
Flux de trésorerie 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $373.0K | $925.0K | $1M | $1M | $1M | |
| Stock-based Comp | $5M | $9M | $14M | $15M | $25M | |
| Deferred Tax | $0 | · | · | · | · | |
| Other Non-cash | · | $-12M | $5M | $300.0K | $7M | |
| Operating Cash Flow | $-48M | $-72M | $-104M | $-90M | $-62M | |
| Investing Cash Flow | · | $0 | $-98.0K | $-265.0K | $-924.0K | |
| Stock Issued | $0 | $9M | $0 | $62M | $71M | |
| Net Stock Activity | · | $9M | $0 | $62M | $71M | |
| Financing Cash Flow | $6M | $10M | $77.0K | $61M | $70M |
Rentabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -32146.7% | |
| Net Margin | · | · | · | · | -31800.7% | |
| EBITDA Margin | · | · | · | · | -31703.3% | |
| ROA | · | -81.1% | -71.5% | -44.4% | -38.2% | |
| ROE | · | -164.3% | -98.4% | -54.4% | -49.1% |
Liquidité et Solvabilité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | · | 3.5 | 4.1 | 9.5 | 12.5 | |
| Quick Ratio | · | 3.4 | 3.9 | 9.3 | 12.4 | |
| Interest Coverage | · | · | · | · | -32146.7 |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 |
Valorisation (TTM) 9
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | · | $300.0K | |
| Net Income TTM | $-60M | $-70M | $-123M | $-106M | $-95M | |
| Market Cap | · | $34M | $118M | $382M | $703M | |
| P/E | -0.6 | -0.4 | -1.0 | -3.0 | -7.1 | |
| P/S | · | · | · | · | 2342.5 | |
| P/B | · | 2.4 | 1.7 | 2.1 | 3.3 | |
| P / Tangible Book | · | 2.4 | 1.7 | 2.1 | 3.3 | |
| P / Cash Flow | · | -0.5 | -1.1 | -4.2 | -11.3 | |
| Earnings Yield | -177.8% | -243.7% | -104.9% | -33.2% | -14.1% |
Compte de résultat 13
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $0 | |
| R&D Expense | $5M | $8M | $10M | $14M | $12M | $12M | $16M | $16M | $19M | $23M | $28M | $31M | $22M | $22M | $20M | $21M | |
| SG&A Expense | $5M | $3M | $4M | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $6M | $7M | $7M | $6M | $8M | |
| Operating Expenses | $9M | $11M | $14M | $19M | $18M | $16M | $22M | $22M | $24M | $29M | $35M | $37M | $29M | $29M | $26M | $29M | |
| Operating Income | $-9M | $-9M | $-14M | $-19M | $-18M | $-16M | $-11M | $-22M | $-24M | $-29M | $-35M | $-37M | $-29M | $-29M | $-26M | $-29M | |
| Interest Income | $37.0K | $77.0K | $133.0K | $233.0K | $400.0K | $554.0K | $692.0K | $900.0K | $1M | $2M | $2M | $1M | $1M | $1M | $370.0K | $146.0K | |
| Other Non-op | $3M | $-529.0K | $-2M | $-64.0K | $2M | $1M | $684.0K | $900.0K | $1M | $2M | $2M | $1M | $1M | $1M | $400.0K | $149.0K | |
| Net Income | $-6M | $-10M | $-16M | $-19M | $-15M | $-15M | $-11M | $-21M | $-23M | $-27M | $-33M | $-36M | $-27M | $-28M | $-26M | $-29M | |
| EPS (Basic) | $-4.22 | $-0.16 | $-0.27 | $-0.32 | $-13.16 | $-0.30 | $-0.22 | $-0.44 | $-0.48 | $-0.55 | $-0.70 | $-0.75 | $-0.58 | $-0.63 | $-0.69 | $-0.77 | |
| EPS (Diluted) | $-4.22 | $-0.16 | $-0.27 | $-0.32 | $-13.16 | $-0.30 | $-0.22 | $-0.44 | $-0.48 | $-0.55 | $-0.70 | $-0.75 | $-0.58 | $-0.63 | $-0.69 | $-0.77 | |
| Shares (Basic) | 1,501,649 | -116,671,031 | 58,745,343 | 58,504,396 | 1,164,984 | -96,064,836 | 48,335,847 | 48,214,893 | 48,087,460 | -95,341,398 | 47,834,122 | 47,706,426 | 47,578,418 | -73,332,188 | 37,516,769 | 37,420,327 | |
| Shares (Diluted) | 1,501,649 | -116,671,031 | 58,745,343 | 58,504,396 | 1,164,984 | -96,064,836 | 48,335,847 | 48,214,893 | 48,087,460 | -95,341,398 | 47,834,122 | 47,706,426 | 47,578,418 | -73,332,188 | 37,516,769 | 37,420,327 | |
| EBITDA | $-9M | · | $-14M | $-19M | $-17M | · | $-11M | $-22M | $-24M | · | $-35M | $-37M | $-29M | · | $-26M | $-29M |
Bilan 18
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $7M | $8M | $18M | $32M | $49M | $57M | $62M | $81M | $111M | $141M | $169M | $193M | $216M | $178M | $202M | |
| Prepaid Expense | $1M | $895.0K | $1M | $2M | $5M | $2M | $4M | $5M | $6M | $5M | $6M | $7M | $7M | $5M | $5M | $5M | |
| Current Assets | $3M | $8M | $10M | $21M | $38M | $51M | $61M | $66M | $86M | $116M | $148M | $175M | $200M | $220M | $183M | $207M | |
| PP&E (Net) | $0 | $120.0K | $324.0K | $380.0K | $495.0K | $678.0K | $906.0K | $1M | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | |
| PP&E (Gross) | $5M | $5M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | |
| Accum. Depreciation | $5M | $5M | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | |
| Other Non-current Assets | $163.0K | $163.0K | $163.0K | $163.0K | · | $0 | $0 | $0 | $154.0K | $154.0K | $154.0K | $154.0K | $154.0K | $154.0K | $154.0K | $155.0K | |
| Total Assets | $9M | $14M | $16M | $27M | $38M | $52M | $62M | $69M | $89M | $120M | $151M | $180M | $205M | $226M | $189M | $213M | |
| Accounts Payable | $12M | $8M | $6M | $5M | $5M | $2M | $3M | $1M | $3M | $4M | $6M | $3M | $8M | $4M | $4M | $5M | |
| Current Liabilities | $21M | $22M | $18M | $17M | $16M | $15M | $19M | $17M | $19M | $28M | $36M | $34M | $26M | $23M | $24M | $26M | |
| Capital Leases | $5M | $5M | $5M | $5M | · | $0 | $0 | $0 | $415.0K | $836.0K | $1M | $2M | $2M | $2M | $3M | $3M | |
| Total Liabilities | $46M | $50M | $47M | $44M | $38M | $38M | $39M | $37M | $39M | $49M | $57M | $55M | $48M | $45M | $46M | $49M | |
| Common Stock | $0 | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | |
| Paid-in Capital | $515M | $509M | $505M | $503M | $502M | $500M | $494M | $492M | $489M | $487M | $484M | $481M | $477M | $473M | $408M | $404M | |
| Retained Earnings | $-552M | $-546M | $-536M | $-520M | $-501M | $-486M | $-471M | $-461M | $-439M | $-416M | $-389M | $-356M | $-320M | $-293M | $-265M | $-239M | |
| Stockholders' Equity | $-37M | $-36M | $-31M | $-17M | $547.0K | $14M | $23M | $31M | $50M | $71M | $95M | $125M | $156M | $180M | $143M | $165M | |
| Liabilities + Equity | $9M | $14M | $16M | $27M | $38M | $52M | $62M | $69M | $89M | $120M | $151M | $180M | $205M | $226M | $189M | $213M | |
| Shares Outstanding | 1,659,612 | 63,464,322 | 58,792,088 | 58,721,588 | 58,401,147 | 58,099,164 | 48,345,533 | 48,326,138 | 48,106,317 | 48,077,599 | 47,907,395 | 47,803,306 | 47,637,321 | 46,336,166 | 36,365,317 | 35,993,458 |
Flux de trésorerie 7
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $120.0K | $19.0K | $56.0K | $115.0K | $183.0K | $228.0K | $228.0K | $229.0K | $240.0K | $368.0K | $270.0K | $290.0K | $293.0K | $298.0K | $300.0K | $288.0K | |
| Stock-based Comp | $956.0K | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | |
| Restructuring | · | · | · | $0 | $556.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $1.0K | · | · | · | $-3M | · | · | · | $-10M | · | · | · | $899.0K | · | · | · | |
| Operating Cash Flow | $-5M | $-8M | $-10M | $-14M | $-16M | $-17M | $-5M | $-19M | $-31M | $-30M | $-27M | $-24M | $-23M | $-24M | $-24M | $-17M | |
| Investing Cash Flow | · | · | · | · | $0 | · | $0 | $0 | $0 | $-8.0K | $-25.0K | $-15.0K | $-50.0K | $-31.0K | $-58.0K | $-166.0K | |
| Financing Cash Flow | $110.0K | $7M | $-6.0K | $-36.0K | $-395.0K | $9M | $-14.0K | $225.0K | $-13.0K | $119.0K | $-41.0K | $115.0K | $-116.0K | $62M | $-96.0K | $-51.0K |
Rentabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -27.1% | · | -40.4% | -39.1% | -24.1% | · | -9.9% | -17.0% | -15.8% | · | -19.6% | -18.2% | -12.6% | · | -11.1% | -13.4% | |
| ROE | 34.5% | · | 381.6% | -255.9% | -61.0% | · | -18.0% | -27.0% | -22.5% | · | -28.1% | -24.7% | -15.8% | · | -13.8% | -16.9% |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | · | 0.5 | 1.2 | 2.3 | · | 3.1 | 3.8 | 4.5 | · | 4.1 | 5.2 | 7.6 | · | 7.7 | 8.1 | |
| Quick Ratio | 0.1 | · | 0.5 | 1.1 | 2.0 | · | 2.9 | 3.5 | 4.2 | · | 4.0 | 5.0 | 7.3 | · | 7.5 | 7.9 |
Efficacité 1
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 |
Valorisation (TTM) 8
| Métrique | Tendance | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | |
| Net Income TTM | $-56M | · | $-60M | $-66M | $-70M | · | $-88M | $-113M | $-120M | · | $-122M | $-118M | $-106M | · | $-102M | $-106M | |
| Market Cap | $13M | · | $40M | $23M | $20M | · | $85M | $66M | $165M | · | $81M | $143M | $128M | · | $280M | $103M | |
| P/E | -0.4 | · | -0.6 | -0.3 | -0.2 | · | -1.0 | -0.6 | -1.4 | · | -0.6 | -1.1 | -1.0 | · | -2.8 | -0.9 | |
| P/B | -0.4 | · | -1.3 | -1.4 | 37.0 | · | 3.7 | 2.1 | 3.3 | · | 0.9 | 1.2 | 0.8 | · | 2.0 | 0.6 | |
| P / Tangible Book | · | · | · | · | 37.0 | · | 3.7 | 2.1 | 3.3 | · | 0.9 | 1.2 | 0.8 | · | 2.0 | 0.6 | |
| P / Cash Flow | -2.5 | · | · | · | -1.2 | · | · | · | -5.4 | · | · | · | -5.6 | · | · | · | |
| Earnings Yield | -223.2% | · | -155.5% | -313.1% | -403.5% | · | -104.6% | -173.0% | -73.0% | · | -160.0% | -93.0% | -100.4% | · | -36.2% | -105.3% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | — | — | — | — | $300.0K |
| Marge d'exploitation % | — | — | — | — | -32146.7% |
| Résultat net | $-60M | $-70M | $-123M | $-106M | $-95M |
| BPA dilué | $-1.01 | $-1.44 | $-2.58 | $-2.74 | $-2.76 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | — | 3.5 | 4.1 | 9.5 | 12.5 |
| Ratio de liquidité réduite | — | 3.4 | 3.9 | 9.3 | 12.4 |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.